Summary.-The demonstration that hexamethylphosphoramide (HMPA) possesses potent carcinogenic properties has raised doubts about the safety of exposure to other phosphoric amides. In order to define a suitable short-term test with which to evaluate such analogues, the response of the Salmonella typhimurium mutation assay of Ames and cell transformation assay of Styles to HMPA and 3 selected analogues has been studied. These analogues were the related leukaemogen phosphoramide, the putative non-carcinogen, phosphoric trianilide and N.N'N"-trimethylphosphorothioic triamide, a compound of unknown and hitherto unpredictable properties. While both tests found the trianilide negative, the Ames test failed to detect phosphoramide as positive and gave an erratic and predominantly negative response to HMPA. In contrast, the transformation assay found both phosphoramide and HMPA positive. This test response profile indicates that the transformation assay is the preferred test with which to evaluate analogues of HMPA for potential carcinogenicity. Some structural requirements for potential carcinogenicity within this class of compounds are tentatively deduced.
A RECENT inhalation study has demonistrated that the widely used solvent hexamethylphosphoramide (HMPA) (I in Fig. 3 ) is a powerful rodent carcinogen (Zapp, 1975) . Since this property had not previously been associated with phosphoric amides, it became of interest to investigate how general this effect was among compounds structurally related to HMPA. Although unexpected (Kimbrough and Gaines, 1973) , the carcinogenicity observed for HMPA has a possible precedent in the earlier observation that the parent compound, phosphoramide (II), produces leukaemia in mice (Vasela, 1962) . For this reason (II) was included in the present study. Conversely, although the carcinogenic anti-tumour agent triethylenephosphoramide (III) (Hadidian et al., 1968) possesses marked structural similarities to HMPA, it was not considered relevant to this study as it contains 3 aziridine rings which would, by themselves, dominate any biological response.
Although the carcinogenicity of HMPA may be uniquely associated with this particular phosphoric amide, it is more likely that a number of structurally related compounds such as hexaethylphosphoramide (IV) will share this property. However, when considering analogues less obviously related to HMPA, the assessment of their likely in vivo properties is difficult, and the use of a short-term test for carcinogenicity becomes desirable.
Selection of test system
The initial phase of short-term test evaluation (McCann and Ames, 1976; McCann et al., 1975; Purchase et al., 1976; Brookes and de Serres, 1976) (Ames, McCann and Yamasaki, 1975) and a cell-transformation assay (Styles, 1977) .
(2) The sensitivity of the test to the particular class of potential carcinogens should be assessed by its ability to give a reproducible positive result with the reference carcinogen of the class (in this case HMPA). In particular, when studving a new class of potential carcinogens, it is important that the test can detect as positive the parent carcinogen before assessing the significance of a negative result given by an analogue.
(3) The test should consistently identify as negative a non-carcinogenic analogue of the reference carcinogen (in the absence of a clearly defined non-carcinogen in the present class, phosphoric trianilide (V) was selected, for reasons discussed later).
This requirement ensures that the test is responding positively to a property of individual compounds which is associated with in vivo carcinogenic activity rather than to some non-specific property of the class as a whole. Cell transforriatioi test.-The methods employed wNhen testing a compound for potential carcinogenicity using growth of manmmalian cells in semni-solid agar have been described in detail in the previous paper (Styles, 1977 
RESULTS
The method of evaluating each test was the same. Two experiments were conducted with each test, the first using HMPA (I), the trianilide (V) and phosphoramide (II) and the second with phosphoramide (II) replaced by the thioamide (VI). Both experiments in each test were accompanied by negative controls and controls known to be positive in that system.
Arnes test
In the first experiment, HMPA gave a strong, dose-related, positive effect in strains TA1535 and TA100, in the presence of S-9 mix (up to 29-fold increase in revertant colonies in TA1535, and 10-fold in TAIOO). Phosphoramide (II) and the trianilide (V) were both negative. In the second experiment, HMPA, together with the phosphoramides (V) and (VI) were all negative. A summary of these results is given in the 
Cell transformation test
The transformation frequencies (corrected to a theoretical LDo) and the cell survivals obtained after treatment of the cells with HMPA (I) (Fig. la) , phosphoramide (II) (Fig. lb) , the trianilide (V) (Fig. Ic) and the thioamide (VI) (Fig. Id) are shown. Both experiments were conducted using duplicate plates at each dose level. Benzidine was used as a positive control and DMSO as negative control (Fig. le) .
A summary of the results obtained is shown in the (Lloyd, 1975) which is a liquid. In this connection, it may be significant that the primary tumours observed in the rat inhalation study occurred in the immediate nasal region. Neither of these possible methods of action can apply to phosphoric trianilide (V) which is a solid (m.p. 212-215°C) and which is also devoid of potential alkylating groups.
The positive effects given by HMPA in these two short-term tests, together with the fact that it produces mutagenic effects in Drosophila (Bemes and Sram, 1969) supports the view that this com- (Purchase et al., 1976) .
The difference in test response observed when comparing HMPA with the phenyl analogue (V) (Figs. la and c) is similar to that found when comparing the test response for the carcinogenic biological alkylating agent, dimethylnitrosamine (VII) with its non-carcinogenic, phenylated analogue, diphenylnitrosamine (VIII) (Fig. 2) . The analogy between these 2 classes of carcinogen is further strengthened by the fact that the erratic response given by the Ames test for HMPA has also been observed for dimethylnitrosamine (Bartsch, Camus and Malaveille, 1976; Purchase et al 1976 Purchase et al , 1977 There is, therefore, sufficient evidence to assume initially that the broad structural requirements for carcinogenicity observed for the nitrosamine carcinogens apply equally to phosphoric amides.
The structure-activity relationships observed for nitrosamines have been reviewed (Druckrey, 1J975) and the major requirement for activity is that the amine nitrogen atom should carry at least one alkyl group having a free ct-position potentially capable of undergoing metabolic ca-hydroxylation. On this basis, it is possible to predict that hexaethylphosphoramide (IV) and phosphoric trimorpholide (IX), for example, would both have carcinogenic potential by analogy with the carcinogens diethylnitrosamine and nitrosomorpholine (X) respectively. Clearly, the first step in the evaluation of such compounds would be to submit them to the cell transformation test, with HMPA as the positive control.
The validity of the above chemical class analogy is partially confirmed by the observation that HMPA, and 2 of its alkylated analogues, undergo in vivo and in vitro a-hydroxylation leading to formaldehyde formation (Jones and Jackson, 1968) . We have confirmed this observation for HMPA using the 8-9 liver fraction described above, a dosedependent relationship between the concentration of HMPA and formaldehyde formation being observed. These experiments, which mirror those described for dimethylnitrosamine (McLean and Day, 1974) together with others aimed at trapping the postulated intermediate alkylating species formed from HMPA will be described in a subsequent publication.
The usefulness of a reliable test is illustrated by the problem posed when attempting to evaluate a compound such as the thioamide (VI). This compound is superficially related to HMPA, yet it has no counterpart in nitrosamine chemistry. The negative result obtained (Fig.  Id) indicates that this compound can be dissociated from the HMPA-type in vivo carcinogenesis.
Finally, it must be mentioned that the in vitro test response and the in vivo leukaemogenicity observed for phosphoramide (II) require an explanation not involving alkyl groups (since none is present). Any separate hypothesis might, of course, be additionally involved in explaining the carcinogenic activity of HMPA itself. Curiously, a similar situation is encountered when considering the carcinogenicity of derivatives of hydrazine (NH2.NH2) (Toth, 1975) . In this case the activity of a variety of alkylated hydrazines can be explained in terms of derived carbonium ions, yet this leaves the activity observed for hydrazine itself unexplained (Biancifiori and Ribacchi, 1962) .
